Literature DB >> 9108093

Chondrocytes as a specific target of ectopic Fos expression in early development.

H Watanabe1, K Saitoh, T Kameda, M Murakami, Y Niikura, S Okazaki, Y Morishita, S Mori, Y Yokouchi, A Kuroiwa, H Iba.   

Abstract

The Finkel-Biskis-Jinkins murine sarcoma virus, which carries v-fos, induces osteosarcomas, whereas high-level expression of exogenous c-fos in transgenic and chimeric mice leads to postnatal development of osteogenic and chondrogenic tumors, respectively. To test whether such target cell specificity of an oncogene can be detected even in early development, we induced ectopic expression of fos in chicken limb buds by microinjecting replication-competent retrovirus into the presumptive leg field of stage 10 embryos. This caused cartilage truncation of all the long bones of the injected leg, which was mainly attributable to chondrodysplasia due to severe retardation of differentiation of the proliferating chondrocytes into mature or hypertrophic chondrocytes, as well as a slight delay in precartilagenous condensation. Expression of genes for all the other known members of chicken AP-1, which include such transforming genes as c-jun and fra-2, however, caused no macroscopic abnormalities in limb formation, indicating a specific function of Fos proteins in embryonic endochondral bone differentiation. The extent of truncation was stronger with v-Fos than with c-Fos, and comparative analysis of these proteins, as well as v-Fos mutants, revealed that strong transforming activity of Fos protein is necessary to cause dysplasia, suggesting that common molecular mechanisms are involved in both embryonic chondrodysplasia and bone tumor formation in postnatal mice.

Entities:  

Mesh:

Year:  1997        PMID: 9108093      PMCID: PMC20556          DOI: 10.1073/pnas.94.8.3994

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  An avian transforming retrovirus isolated from a nephroblastoma that carries the fos gene as the oncogene.

Authors:  M Nishizawa; N Goto; S Kawai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 3.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Transforming potential and growth stimulating activity of the v-fos and c-fos genes carried by avian retrovirus vectors.

Authors:  H Iba; Y Shindo; H Nishina; T Yoshida
Journal:  Oncogene Res       Date:  1988

5.  The chicken c-fos gene: cloning and nucleotide sequence analysis.

Authors:  K T Fujiwara; K Ashida; H Nishina; H Iba; N Miyajima; M Nishizawa; S Kawai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Deregulated c-fos expression interferes with normal bone development in transgenic mice.

Authors:  U Rüther; C Garber; D Komitowski; R Müller; E F Wagner
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

7.  c-fos expression induces bone tumors in transgenic mice.

Authors:  U Rüther; D Komitowski; F R Schubert; E F Wagner
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

8.  fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen.

Authors:  D R Cohen; T Curran
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

9.  Detection of fos protein during osteogenesis by monoclonal antibodies.

Authors:  P De Togni; H Niman; V Raymond; P Sawchenko; I M Verma
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  7 in total

Review 1.  Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

Authors:  C Kappen; A Neubüser; R Balling; R Finnell
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-12

2.  A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E.

Authors:  Philipp G Maass; Jutta Wirth; Atakan Aydin; Andreas Rump; Sigmar Stricker; Sigrid Tinschert; Miguel Otero; Kaneyuki Tsuchimochi; Mary B Goldring; Friedrich C Luft; Sylvia Bähring
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

3.  Retinoic acid and the transcription factor MafB act together and differentially to regulate aggrecan and matrix metalloproteinase gene expression in neonatal chondrocytes.

Authors:  Yao Zhang; A Catharine Ross
Journal:  J Cell Biochem       Date:  2013-02       Impact factor: 4.429

4.  Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development.

Authors:  M Iwamoto; Y Higuchi; E Koyama; M Enomoto-Iwamoto; K Kurisu; H Yeh; W R Abrams; J Rosenbloom; M Pacifici
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

5.  C-Fos regulation by the MAPK and PKC pathways in intervertebral disc cells.

Authors:  Katsuya Yokoyama; Akihiko Hiyama; Fumiyuki Arai; Tadashi Nukaga; Daisuke Sakai; Joji Mochida
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

Review 6.  The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.

Authors:  Ines Garces de Los Fayos Alonso; Huan-Chang Liang; Suzanne D Turner; Sabine Lagger; Olaf Merkel; Lukas Kenner
Journal:  Cancers (Basel)       Date:  2018-03-28       Impact factor: 6.639

7.  c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells.

Authors:  Ander Abarrategi; Stefano Gambera; Arantzazu Alfranca; Miguel A Rodriguez-Milla; Raquel Perez-Tavarez; Kevin Rouault-Pierre; Alexander Waclawiczek; Probir Chakravarty; Francisca Mulero; César Trigueros; Samuel Navarro; Dominique Bonnet; Javier García-Castro
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.